Incidence of cancer among patients with systemic sclerosis in Korea results from a single centre

Scandinavian Journal of Rheumatology

Volumn 38, Issue 4, 2009, Pages 299-303

  Kang, K Y ^a   Yim, H W ^b   Kim, I J ^a   Yoon, J U ^a   Ju, J H ^a   Kim, H Y ^a   Park, S H ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; PENICILLAMINE;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER REGISTRY; COMORBIDITY; CONTROLLED STUDY; DISEASE DURATION; ESOPHAGUS CANCER; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; KOREA; LIVER CANCER; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PANCREAS CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STANDARDIZED INCIDENCE RATIO; STOMACH CANCER; SYSTEMIC SCLEROSIS; UNDIFFERENTIATED CARCINOMA;

ADULT; AGE DISTRIBUTION; COHORT STUDIES; COMORBIDITY; CONFIDENCE INTERVALS; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; KOREA; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS; PANCREATIC NEOPLASMS; PROBABILITY; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SEX DISTRIBUTION; STOMACH NEOPLASMS;

EID: 70350686436     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740802642062     Document Type: Article

References (21)

1. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66:940-944
2. Abu-Shakra M, Guillemin F, Lee P. Cancer in systemic sclerosis. Arthritis Rheum 1993;36:460-464
3. Derk CT, Rasheed M, Artlett CM, Jimenez SA. A cohort study of cancer incidence in systemic sclerosis. J Rheumatol 2006;33:1113-1116
4. Rosenthal AK, McLaughlin JK, Gridley G, Nyrén O. Incidence of cancer among patients with systemic sclerosis. Cancer 1995;76:910-914
5. Higuchi M, Horiuchi T, Ishibashi N, Yoshizawa S, Niho Y, Nagasawa K. Anticentromere antibody as a risk factor for cancer in patients with systemic sclerosis. Clin Rheumatol 2000;19:123-126
6. Hill CL, Nguyen AM, Roder D, Roberts-Thomson P. Risk of cancer in patients with scleroderma: A population-based cohort study. Ann Rheum Dis 2003;62:728-731
7. Duncan SC, Winkelmann RK. Cancer and scleroderma. Arch Dermatol 1979;115:950-955
8. Chatterjee S, Dombi GW, Severson RK, Mayes MD. Risk of malignancy in scleroderma: A population-based cohort study. Arthritis Rheum 2005;52:2415-2424
9. Cancer incidence in Korea 1999-2001. Republic of Korea: Ministry of Health and Welfare, 2005.
10. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988;15:202-205
11. Hesselstrand R, Scheja A, Akesson A. Mortality and causes of death in a Swedish series of systemic sclerosis patients. Ann Rheum Dis 1998;57:682-686
12. Czirják L, Kumánovics G, Varjú C, Nagy Z, Pákozdi A, Szekanecz Z, et al. Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis 2008;67:59-63.
13. Yang Y, Fujita J, Tokuda M, Bandoh S, Ishida T. Lung cancer associated with several connective tissue diseases: With a review of literature. Rheumatol Int 2001;21:106-111 (Pubitemid 33071192)
14. Bernatsky S, Ramsey-Goldman R, Clarke A. Malignancy and autoimmunity. Curr Opin Rheumatol 2006;18:129-134
15. Artinian V, Kvale PA. Cancer and interstitial lung disease. Curr Opin Pulm Med 2004;10:425-434
16. Bouros D, Hatzakis K, Labrakis H, Zeibecoglou K. Association of malignancy with diseases causing interstitial pulmonary changes. Chest 2002;121:1278-1289
17. Kanaji N, Fujita J, Bandoh S, Fukumoto T, Ishikawa M, Haba R, et al. Small cell lung cancer associated with systemic sclerosis. Intern Med 2005;44:315-318
18. Peters-Golden M, Wise RA, Hochberg M, Stevens MB, Wigley FM. Incidence of lung cancer in systemic sclerosis. J Rheumatol 1985;12:1136-1139
19. Pontifex EK, Hill CL, Roberts-Thomson P. Risk factors for lung cancer in patients with scleroderma: A nested case-control study. Ann Rheum Dis 2007;66:551-553
20. Katzka DA, Reynolds JC, Saul SH, Plotkin A, Lang CA, Ouyang A, et al. Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma. Am J Med 1987;82:46-52.
21. Rothfield N, Kurtzman S, Vazques-Abad D, Charron C, Daniels L, Greenberg B. Association of anti-topoisomerase I with cancer. Arthritis Rheum 1992;35:724.